Announcements Trials

Browse Landscape

Status

Not yet recruiting 2 No longer available 1 Active not recruiting 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Interventions

TIC10 compound 2 3-Iodobenzylguanidine 2 tucatinib 1 rindopepimut 1 pembrolizumab 1 pegfilgrastim 1 paclitaxel-Angiopep-2 conjugate 1 omburtamab I-131 1 mogamulizumab 1 gallium maltolate 1 fluorodopa F 18 1 efineptakin alfa 1 avapritinib 1 Vorinostat 1 Potassium Iodide 1 OKN 007 1 Ketoconazole 1 Ipilimumab 1 Granulocyte Colony-Stimulating Factor 1 Fenretinide 1 Cancer Vaccines 1 Adjuvants, Immunologic 1 ABT-414 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × gallium maltolate × CNS × Clear all

NCT06404034 2026-03-04

Expanded Access to Gallium Maltolate (GaM)

Imaging Biometrics, LLC

No longer available

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡